Form 4 for CNMD CONMED Corp
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-05 · accession 0001127602-21-028634 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-08 | 2021-11-05 | CNMD | TRYNISKI MARK E | Dir | M - OptEx | $65.71 | +13.0K | 10.1K | New | +$855.5K |
| DM | 2021-11-08 | 2021-11-05 | CNMD | TRYNISKI MARK E | Dir | S - Sale+OE | $156.52 | -13.0K | 8,296 | -61% | -$2.04M |
| DM | 2021-11-08 | 2021-11-05 | CNMD | TRYNISKI MARK E | Dir | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | M | A | 4,892 | $51.90 | 13,188 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-05 | S | D | 4,792 | $156.51 | 8,396 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2021-11-05 | S | D | 100 | $157.11 | 8,296 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-05 | M | A | 3,399 | $69.03 | 11,695 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-05 | S | D | 2,899 | $156.44 | 8,796 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Common | Common Stock | 2021-11-05 | S | D | 100 | $157.05 | 8,296 | D | — | — | |
| 7 | Common | Common Stock | 2021-11-05 | M | A | 2,886 | $79.94 | 11,182 | D | — | — | |
| 8 | Common | Common Stock | 2021-11-05 | S | D | 2,386 | $156.44 | 8,796 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 9 | Common | Common Stock | 2021-11-05 | S | D | 500 | $156.95 | 8,296 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 10 | Common | Common Stock | 2021-11-05 | M | A | 1,843 | $73.94 | 10,139 | D | — | — | |
| 11 | Common | Common Stock | 2021-11-05 | S | D | 1,743 | $156.48 | 8,396 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 12 | Common | Common Stock | 2021-11-05 | S | D | 500 | $157.06 | 8,296 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 13 | Derivative | Options To Purchase Common Stock | 2021-11-05 | M | D | 4,892 | $0.00 | 0 | D | $51.90 · 2018-06-01 to 2027-06-01 | 4,892 Common Stock | (F7) The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 14 | Derivative | Options To Purchase Common Stock | 2021-11-05 | M | D | 1,843 | $0.00 | 0 | D | $73.94 · 2021-06-01 to 2030-06-01 | 1,843 Common Stock | (F8) The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 15 | Derivative | Options To Purchase Common Stock | 2021-11-05 | M | D | 2,886 | $0.00 | 0 | D | $79.94 · 2020-06-01 to 2029-06-03 | 2,886 Common Stock | (F7) The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 16 | Derivative | Options To Purchase Common Stock | 2021-11-05 | M | D | 3,399 | $0.00 | 0 | D | $69.03 · 2019-06-01 to 2028-06-01 | 3,399 Common Stock | (F7) The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |